Intensity and focus of heart failure disease management after hospital discharge
Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions. Between September 2001 and June 2002, we enrolled 32 patients admitte...
Gespeichert in:
Veröffentlicht in: | The American heart journal 2005-04, Vol.149 (4), p.715-721 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 721 |
---|---|
container_issue | 4 |
container_start_page | 715 |
container_title | The American heart journal |
container_volume | 149 |
creator | Shah, Monica R. Flavell, Carol M. Weintraub, Joanne R. Young, Michelle A. Hasselblad, Vic Fang, James C. Nohria, Anju Lewis, Eldrin F. Givertz, Michael M. Mudge, Gilbert Stevenson, Lynne W. |
description | Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions.
Between September 2001 and June 2002, we enrolled 32 patients admitted to the Brigham and Women's Hospital Heart Failure Services, Boston, Mass, with decompensated heart failure. The intensity of care and outcomes of these patients were prospectively tracked for more than 90 days. During this time, there were 325 patient contacts (median 8.5 per patient), including 247 calls (median 7 per patient) and 78 clinic visits (median 2 per patient). Brigham and Women's Hospital clinicians adjusted diuretics a total of 109 times (median 2.5 times per patient). When frequency of diuretic adjustments was used to estimate the intensity of care, higher values of blood urea nitrogen at discharge predicted an increased intensity of care during the 90-day follow-up (relative risk [RR] 1.2, 95% confidence interval [CI] 1.0-1.3,
P = .02). When frequency of clinic visits, telephone calls, and diuretic adjustments were used to estimate intensity of care, discharge creatinine (RR 1.03, 95% CI 0.99-1.06,
P = .05), discharge blood urea nitrogen (RR 1.13, 95% CI 1.04-1.23,
P = .004), and length of stay (RR 1.07, 95% CI 1.00-1.13,
P = .04) were predictors of the composite end point.
Even after undergoing optimization of medications during admission for acute heart failure, patients in a comprehensive disease management program required frequent interventions to maintain clinical stability. Renal dysfunction was the strongest predictor of increased interventions and worse outcome. |
doi_str_mv | 10.1016/j.ahj.2004.11.020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67991077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870304008725</els_id><sourcerecordid>67991077</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-ced591d583a515cb0e770a204cf4d5b18d562f11199d979d0eb5f6bdb1990dae3</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMo7rj6A7xIg-it26qeTqeDJ1n8WFjQg55DdVLZSdMfY9It7L83wwwsePBUpHiq6uWJEK8RKgRsPwwVHYaqBmgqxApqeCJ2CFqVrWqap2IHAHXZKdhfiRcpDfnZ1l37XFyh1BqU7Hbix-288pzC-lDQ7Aq_2C0Viy8OTHEtPIVxi1y4kJgSFxPNdM8Tz2tBfuVYHJZ0DCuNJ8IeKN7zS_HM05j41aVei19fPv-8-Vbeff96e_PprrQN6LW07KRGJ7s9SZS2B1YKqIbG-sbJHjsn29ojotZOK-2Ae-nb3vW5AY54fy3en_ce4_J747SaKUfgcaSZly2ZVmmNoFQG3_4DDssW55zNoISmaVS-mik8UzYuKUX25hjDRPHBIJiTbDOYLNucZBtEk2XnmTeXzVs_sXucuNjNwLsLQMnS6CPNNqRHLn8T4P50_OOZ4yzsT-Bokg08Z0chsl2NW8J_YvwFC1-b4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504447204</pqid></control><display><type>article</type><title>Intensity and focus of heart failure disease management after hospital discharge</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shah, Monica R. ; Flavell, Carol M. ; Weintraub, Joanne R. ; Young, Michelle A. ; Hasselblad, Vic ; Fang, James C. ; Nohria, Anju ; Lewis, Eldrin F. ; Givertz, Michael M. ; Mudge, Gilbert ; Stevenson, Lynne W.</creator><creatorcontrib>Shah, Monica R. ; Flavell, Carol M. ; Weintraub, Joanne R. ; Young, Michelle A. ; Hasselblad, Vic ; Fang, James C. ; Nohria, Anju ; Lewis, Eldrin F. ; Givertz, Michael M. ; Mudge, Gilbert ; Stevenson, Lynne W.</creatorcontrib><description>Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions.
Between September 2001 and June 2002, we enrolled 32 patients admitted to the Brigham and Women's Hospital Heart Failure Services, Boston, Mass, with decompensated heart failure. The intensity of care and outcomes of these patients were prospectively tracked for more than 90 days. During this time, there were 325 patient contacts (median 8.5 per patient), including 247 calls (median 7 per patient) and 78 clinic visits (median 2 per patient). Brigham and Women's Hospital clinicians adjusted diuretics a total of 109 times (median 2.5 times per patient). When frequency of diuretic adjustments was used to estimate the intensity of care, higher values of blood urea nitrogen at discharge predicted an increased intensity of care during the 90-day follow-up (relative risk [RR] 1.2, 95% confidence interval [CI] 1.0-1.3,
P = .02). When frequency of clinic visits, telephone calls, and diuretic adjustments were used to estimate intensity of care, discharge creatinine (RR 1.03, 95% CI 0.99-1.06,
P = .05), discharge blood urea nitrogen (RR 1.13, 95% CI 1.04-1.23,
P = .004), and length of stay (RR 1.07, 95% CI 1.00-1.13,
P = .04) were predictors of the composite end point.
Even after undergoing optimization of medications during admission for acute heart failure, patients in a comprehensive disease management program required frequent interventions to maintain clinical stability. Renal dysfunction was the strongest predictor of increased interventions and worse outcome.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2004.11.020</identifier><identifier>PMID: 15990758</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject><![CDATA[Adrenergic beta-Antagonists - administration & dosage ; Adrenergic beta-Antagonists - therapeutic use ; Adult ; Age ; Aged ; Ambulatory Care - statistics & numerical data ; Angiotensin-Converting Enzyme Inhibitors - administration & dosage ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Biological and medical sciences ; Blood Urea Nitrogen ; Cardiology. Vascular system ; Case Management - statistics & numerical data ; Creatinine - blood ; Disease management ; Diuretics - administration & dosage ; Diuretics - therapeutic use ; Drug therapy ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Heart ; Heart failure ; Heart Failure - complications ; Heart Failure - drug therapy ; Heart Failure - metabolism ; Heart Failure - nursing ; Heart Failure - therapy ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart rate ; Heart Transplantation - statistics & numerical data ; Hemodynamics ; Hospitalization ; Hospitalization - statistics & numerical data ; Humans ; Kidney Diseases - complications ; Kidney Diseases - urine ; Male ; Medical prognosis ; Medical sciences ; Middle Aged ; Nurses ; Office Visits - statistics & numerical data ; Patients ; Prospective Studies ; Risk Factors ; Stroke Volume ; Telephone - statistics & numerical data ; Variables ; Vasodilator Agents - administration & dosage ; Vasodilator Agents - therapeutic use ; Water-Electrolyte Imbalance - drug therapy ; Water-Electrolyte Imbalance - etiology]]></subject><ispartof>The American heart journal, 2005-04, Vol.149 (4), p.715-721</ispartof><rights>2005</rights><rights>2005 INIST-CNRS</rights><rights>Copyright Elsevier Limited Apr 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-ced591d583a515cb0e770a204cf4d5b18d562f11199d979d0eb5f6bdb1990dae3</citedby><cites>FETCH-LOGICAL-c409t-ced591d583a515cb0e770a204cf4d5b18d562f11199d979d0eb5f6bdb1990dae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002870304008725$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16740134$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15990758$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shah, Monica R.</creatorcontrib><creatorcontrib>Flavell, Carol M.</creatorcontrib><creatorcontrib>Weintraub, Joanne R.</creatorcontrib><creatorcontrib>Young, Michelle A.</creatorcontrib><creatorcontrib>Hasselblad, Vic</creatorcontrib><creatorcontrib>Fang, James C.</creatorcontrib><creatorcontrib>Nohria, Anju</creatorcontrib><creatorcontrib>Lewis, Eldrin F.</creatorcontrib><creatorcontrib>Givertz, Michael M.</creatorcontrib><creatorcontrib>Mudge, Gilbert</creatorcontrib><creatorcontrib>Stevenson, Lynne W.</creatorcontrib><title>Intensity and focus of heart failure disease management after hospital discharge</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions.
Between September 2001 and June 2002, we enrolled 32 patients admitted to the Brigham and Women's Hospital Heart Failure Services, Boston, Mass, with decompensated heart failure. The intensity of care and outcomes of these patients were prospectively tracked for more than 90 days. During this time, there were 325 patient contacts (median 8.5 per patient), including 247 calls (median 7 per patient) and 78 clinic visits (median 2 per patient). Brigham and Women's Hospital clinicians adjusted diuretics a total of 109 times (median 2.5 times per patient). When frequency of diuretic adjustments was used to estimate the intensity of care, higher values of blood urea nitrogen at discharge predicted an increased intensity of care during the 90-day follow-up (relative risk [RR] 1.2, 95% confidence interval [CI] 1.0-1.3,
P = .02). When frequency of clinic visits, telephone calls, and diuretic adjustments were used to estimate intensity of care, discharge creatinine (RR 1.03, 95% CI 0.99-1.06,
P = .05), discharge blood urea nitrogen (RR 1.13, 95% CI 1.04-1.23,
P = .004), and length of stay (RR 1.07, 95% CI 1.00-1.13,
P = .04) were predictors of the composite end point.
Even after undergoing optimization of medications during admission for acute heart failure, patients in a comprehensive disease management program required frequent interventions to maintain clinical stability. Renal dysfunction was the strongest predictor of increased interventions and worse outcome.</description><subject>Adrenergic beta-Antagonists - administration & dosage</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Ambulatory Care - statistics & numerical data</subject><subject>Angiotensin-Converting Enzyme Inhibitors - administration & dosage</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood Urea Nitrogen</subject><subject>Cardiology. Vascular system</subject><subject>Case Management - statistics & numerical data</subject><subject>Creatinine - blood</subject><subject>Disease management</subject><subject>Diuretics - administration & dosage</subject><subject>Diuretics - therapeutic use</subject><subject>Drug therapy</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Heart failure</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - metabolism</subject><subject>Heart Failure - nursing</subject><subject>Heart Failure - therapy</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Heart rate</subject><subject>Heart Transplantation - statistics & numerical data</subject><subject>Hemodynamics</subject><subject>Hospitalization</subject><subject>Hospitalization - statistics & numerical data</subject><subject>Humans</subject><subject>Kidney Diseases - complications</subject><subject>Kidney Diseases - urine</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nurses</subject><subject>Office Visits - statistics & numerical data</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Stroke Volume</subject><subject>Telephone - statistics & numerical data</subject><subject>Variables</subject><subject>Vasodilator Agents - administration & dosage</subject><subject>Vasodilator Agents - therapeutic use</subject><subject>Water-Electrolyte Imbalance - drug therapy</subject><subject>Water-Electrolyte Imbalance - etiology</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kU2LFDEQhoMo7rj6A7xIg-it26qeTqeDJ1n8WFjQg55DdVLZSdMfY9It7L83wwwsePBUpHiq6uWJEK8RKgRsPwwVHYaqBmgqxApqeCJ2CFqVrWqap2IHAHXZKdhfiRcpDfnZ1l37XFyh1BqU7Hbix-288pzC-lDQ7Aq_2C0Viy8OTHEtPIVxi1y4kJgSFxPNdM8Tz2tBfuVYHJZ0DCuNJ8IeKN7zS_HM05j41aVei19fPv-8-Vbeff96e_PprrQN6LW07KRGJ7s9SZS2B1YKqIbG-sbJHjsn29ojotZOK-2Ae-nb3vW5AY54fy3en_ce4_J747SaKUfgcaSZly2ZVmmNoFQG3_4DDssW55zNoISmaVS-mik8UzYuKUX25hjDRPHBIJiTbDOYLNucZBtEk2XnmTeXzVs_sXucuNjNwLsLQMnS6CPNNqRHLn8T4P50_OOZ4yzsT-Bokg08Z0chsl2NW8J_YvwFC1-b4A</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Shah, Monica R.</creator><creator>Flavell, Carol M.</creator><creator>Weintraub, Joanne R.</creator><creator>Young, Michelle A.</creator><creator>Hasselblad, Vic</creator><creator>Fang, James C.</creator><creator>Nohria, Anju</creator><creator>Lewis, Eldrin F.</creator><creator>Givertz, Michael M.</creator><creator>Mudge, Gilbert</creator><creator>Stevenson, Lynne W.</creator><general>Mosby, Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>Intensity and focus of heart failure disease management after hospital discharge</title><author>Shah, Monica R. ; Flavell, Carol M. ; Weintraub, Joanne R. ; Young, Michelle A. ; Hasselblad, Vic ; Fang, James C. ; Nohria, Anju ; Lewis, Eldrin F. ; Givertz, Michael M. ; Mudge, Gilbert ; Stevenson, Lynne W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-ced591d583a515cb0e770a204cf4d5b18d562f11199d979d0eb5f6bdb1990dae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adrenergic beta-Antagonists - administration & dosage</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Ambulatory Care - statistics & numerical data</topic><topic>Angiotensin-Converting Enzyme Inhibitors - administration & dosage</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood Urea Nitrogen</topic><topic>Cardiology. Vascular system</topic><topic>Case Management - statistics & numerical data</topic><topic>Creatinine - blood</topic><topic>Disease management</topic><topic>Diuretics - administration & dosage</topic><topic>Diuretics - therapeutic use</topic><topic>Drug therapy</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Heart failure</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - metabolism</topic><topic>Heart Failure - nursing</topic><topic>Heart Failure - therapy</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Heart rate</topic><topic>Heart Transplantation - statistics & numerical data</topic><topic>Hemodynamics</topic><topic>Hospitalization</topic><topic>Hospitalization - statistics & numerical data</topic><topic>Humans</topic><topic>Kidney Diseases - complications</topic><topic>Kidney Diseases - urine</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nurses</topic><topic>Office Visits - statistics & numerical data</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Stroke Volume</topic><topic>Telephone - statistics & numerical data</topic><topic>Variables</topic><topic>Vasodilator Agents - administration & dosage</topic><topic>Vasodilator Agents - therapeutic use</topic><topic>Water-Electrolyte Imbalance - drug therapy</topic><topic>Water-Electrolyte Imbalance - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, Monica R.</creatorcontrib><creatorcontrib>Flavell, Carol M.</creatorcontrib><creatorcontrib>Weintraub, Joanne R.</creatorcontrib><creatorcontrib>Young, Michelle A.</creatorcontrib><creatorcontrib>Hasselblad, Vic</creatorcontrib><creatorcontrib>Fang, James C.</creatorcontrib><creatorcontrib>Nohria, Anju</creatorcontrib><creatorcontrib>Lewis, Eldrin F.</creatorcontrib><creatorcontrib>Givertz, Michael M.</creatorcontrib><creatorcontrib>Mudge, Gilbert</creatorcontrib><creatorcontrib>Stevenson, Lynne W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, Monica R.</au><au>Flavell, Carol M.</au><au>Weintraub, Joanne R.</au><au>Young, Michelle A.</au><au>Hasselblad, Vic</au><au>Fang, James C.</au><au>Nohria, Anju</au><au>Lewis, Eldrin F.</au><au>Givertz, Michael M.</au><au>Mudge, Gilbert</au><au>Stevenson, Lynne W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intensity and focus of heart failure disease management after hospital discharge</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>149</volume><issue>4</issue><spage>715</spage><epage>721</epage><pages>715-721</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions.
Between September 2001 and June 2002, we enrolled 32 patients admitted to the Brigham and Women's Hospital Heart Failure Services, Boston, Mass, with decompensated heart failure. The intensity of care and outcomes of these patients were prospectively tracked for more than 90 days. During this time, there were 325 patient contacts (median 8.5 per patient), including 247 calls (median 7 per patient) and 78 clinic visits (median 2 per patient). Brigham and Women's Hospital clinicians adjusted diuretics a total of 109 times (median 2.5 times per patient). When frequency of diuretic adjustments was used to estimate the intensity of care, higher values of blood urea nitrogen at discharge predicted an increased intensity of care during the 90-day follow-up (relative risk [RR] 1.2, 95% confidence interval [CI] 1.0-1.3,
P = .02). When frequency of clinic visits, telephone calls, and diuretic adjustments were used to estimate intensity of care, discharge creatinine (RR 1.03, 95% CI 0.99-1.06,
P = .05), discharge blood urea nitrogen (RR 1.13, 95% CI 1.04-1.23,
P = .004), and length of stay (RR 1.07, 95% CI 1.00-1.13,
P = .04) were predictors of the composite end point.
Even after undergoing optimization of medications during admission for acute heart failure, patients in a comprehensive disease management program required frequent interventions to maintain clinical stability. Renal dysfunction was the strongest predictor of increased interventions and worse outcome.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>15990758</pmid><doi>10.1016/j.ahj.2004.11.020</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-8703 |
ispartof | The American heart journal, 2005-04, Vol.149 (4), p.715-721 |
issn | 0002-8703 1097-6744 |
language | eng |
recordid | cdi_proquest_miscellaneous_67991077 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenergic beta-Antagonists - administration & dosage Adrenergic beta-Antagonists - therapeutic use Adult Age Aged Ambulatory Care - statistics & numerical data Angiotensin-Converting Enzyme Inhibitors - administration & dosage Angiotensin-Converting Enzyme Inhibitors - therapeutic use Biological and medical sciences Blood Urea Nitrogen Cardiology. Vascular system Case Management - statistics & numerical data Creatinine - blood Disease management Diuretics - administration & dosage Diuretics - therapeutic use Drug therapy Drug Therapy, Combination Female Follow-Up Studies Heart Heart failure Heart Failure - complications Heart Failure - drug therapy Heart Failure - metabolism Heart Failure - nursing Heart Failure - therapy Heart failure, cardiogenic pulmonary edema, cardiac enlargement Heart rate Heart Transplantation - statistics & numerical data Hemodynamics Hospitalization Hospitalization - statistics & numerical data Humans Kidney Diseases - complications Kidney Diseases - urine Male Medical prognosis Medical sciences Middle Aged Nurses Office Visits - statistics & numerical data Patients Prospective Studies Risk Factors Stroke Volume Telephone - statistics & numerical data Variables Vasodilator Agents - administration & dosage Vasodilator Agents - therapeutic use Water-Electrolyte Imbalance - drug therapy Water-Electrolyte Imbalance - etiology |
title | Intensity and focus of heart failure disease management after hospital discharge |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T23%3A05%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intensity%20and%20focus%20of%20heart%20failure%20disease%20management%20after%20hospital%20discharge&rft.jtitle=The%20American%20heart%20journal&rft.au=Shah,%20Monica%20R.&rft.date=2005-04-01&rft.volume=149&rft.issue=4&rft.spage=715&rft.epage=721&rft.pages=715-721&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2004.11.020&rft_dat=%3Cproquest_cross%3E67991077%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504447204&rft_id=info:pmid/15990758&rft_els_id=S0002870304008725&rfr_iscdi=true |